Back

Drug-drug interactions of NOACs with comedication: prevalence and implications for adverse events in patients with atrial fibrillation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Stroke prevention in atrial fibrillation Oral Anticoagulation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Elisa Hennings

University Hospital Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
Age-dependent association between heart failure and stroke risk in atrial fibrillation: a nationwide cohort study
Doctor E. Jalli (Pori, FI)
Abstract Slides Video
Presentation thumbnail
Does the effect of anticoagulation on stroke risk differ by CHA2DS2-VA score in patients with atrial fibrillation? A nationwide cohort study.
Mr L. Leppiniemi (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Real-world detection of atrial fibrillation after ischaemic stroke using the FIND-AFDAS meta-machine learning algorithm: an unmet need
Doctor C. Simela (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Discordance in estimated kidney function by different equations and outcomes in patients with atrial fibrillation on oral anticoagulation: a COMBINE-AF analysis
Assistant Professor P. Krisai (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prevention in atrial fibrillation

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Evolution of anticoagulation therapy in patients with atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in atrial fibrillation: new insights
thumbnail
Congress Session
Practical insights for your atrial fibrillation patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources